5-Hydroxytryptamine 2B receptor antagonism restores ATP and reduces tubulointerstitial fibrosis in the renal cortices of aged mice
- 23 March 2026
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 393 (5) , 104321
Abstract
No abstract availableKeywords
Funding Information
- U.S. Department of Veterans Affairs (T32-5T32DK101357)
- U.S. Department of Veterans Affairs (BX005218)
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Institute of Environmental Health Sciences
This publication has 80 references indexed in Scilit:
- Renal inflammation combined with renal function reserve reduction accelerate kidney aging via pentose phosphate pathwayiScience, 2024
- Global and tissue-specific aging effects on murine proteomesCell Reports, 2023
- The development of small-molecule inhibitors targeting hexokinase 2Drug Discovery Today, 2022
- The innate immune system in human kidney inflammagingJournal Of Nephrology, 2021
- A collagen-binding protein enables molecular imaging of kidney fibrosis in vivoKidney International, 2020
- The 5-hydroxytryptamine receptor 1F stimulates mitochondrial biogenesis and angiogenesis in endothelial cellsBiochemical Pharmacology, 2019
- The role of α-smooth muscle actin in fibroblast-mediated matrix contraction and remodelingBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2017
- Multiple functions of p21 in cell cycle, apoptosis and transcriptional regulation after DNA damageDNA Repair, 2016
- Aging-related renal injury and inflammation are associated with downregulation of Klotho and induction of RIG-I/NF-κB signaling pathway in senescence-accelerated miceAging Clinical and Experimental Research, 2015
- Activation of NF-κB Is Required for PDGF-B Chain to Transform NIH3T3 CellsExperimental Cell Research, 2002